Use of substituted 1,2,3 indolizine de- rivatives for treating diseases associated with a pathological choroidal angiogenesis

Details for Australian Patent Application No. 2005216671 (hide)

Owner sanofi-aventis

Inventors Rakic, Jean-Marie; Bono, Francoise; Guillo, Nathalie; Bordes, MarieFrancoise; Badorc, Alain; Foidart, JeanMichel; Noel, Agnes

Agent Davies Collison Cave

Pub. Number AU-B-2005216671

PCT Pub. Number WO2005/082457

Priority 0401094 05.02.04 FR

Filing date 4 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 16 September 2010

International Classifications

A61K 31/437 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/082457 Priority application(s): WO2005/082457

16 September 2010 Application Accepted

  Published as AU-B-2005216671

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216690-Smoking article and apparatus and process for manufacturing a smoking article

2005216663-Topical compositions associating sodium hyaluronate fragments and retinoid useful for cosmetic and medical dermatology